Retina Specialists Allen C. Ho, MD, FACS, and Katherine Talcott, MD, discuss three complex patient cases and ways to limit loss to follow-up in patients with diabetic eye disease.
Supported by an independent medical education grant from Regeneron Pharmaceuticals.
Upon completion of this activity, the participant should be able to:
This educational activity is provided by Evolve Medical Education LLC (Evolve).
Accreditation Statement
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Allen C. Ho, MD, FACS
Wills Eye Hospital
Attending Surgeon
Director of Retina Research
Professor of Ophthalmology
Thomas Jefferson University
Mid Atlantic Retina
President, The Retina Society
Katherine Talcott, MD
Assistant Professor of Ophthalmology
Associate Program Director Ophthalmology Residency
Cleveland Clinic
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Allen C. Ho, MD, FACS, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Adverum, Aerie Pharmaceuticals, AGTC, Alcon Vision, Aldeyra, Allergan, Apellis, Asclepix, Beaver-Visitec International, Chengdu Kanghong Biotechnology, Genentech, Regenxbio, Meira GTX Gyroscope, Clearside, Iveric/Ophthotech, Janssen/Johnson&Johnson Vision, Lineage, Notal Vision, Ocular Therapeutixs, ONL, Regeneron Pharmaceuticals. Grant/Research Support: Adverum, Aerie Pharmaceuticals, AGTC, Alcon Vision, Aldeyra, Allergan, Apellis, Asclepix, Chengdu Kanghong Biotechnolog, Genentech, Graybug, Gyroscope, Iveric/Ophthotech, Janssen/Johnson&Johnson Vision, Lineage, Lumithera, Meira G TX , National Eye Institute, Notal Vision, Novartis, ProQR, Regeneron Pharmaceuticals, Inc., and Regenxbio. Other support: Covalent.
Katherine Talcott, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Genentech and Grant/ResearchSupport: Carl Zeiss Meditec.
The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve and Regeneron Pharmaceuticals.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Treating Outside the Box: New Pathways to Retinal Vascular Stability
July 17, 2026
Montreal
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
1.00 program credit
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
